Quoted from http://www.fiercepharma.com/story/takeda-gets-enough-takers-complete-23b-actos-settlement/2015-09-14
Takeda gets enough takers to complete $2.3B Actos settlement
Drugmaker agrees to kick in another $100M if enough claims pan out legit
A month ago it appeared like Takeda might not get enough takers to move forward with its sweeping $2.3 billion offer to settle thousands of claims over the cancer risks of diabetes drug Actos. But over the weekend, the Japanese drugmaker said it had raised the offer by $100 million if certain conditions are hit and now has enough on board to trigger the $2.3 billion settlement.
The company said it has 96% of the claimants signed up, and in the process has settled 7 of the 9 cases that have already gone to trial as well as many of the estimated 8,000 cases pending in state and federal courts. If 97% of the claims match up with the settlement criteria, Takeda said has agreed to cough up $2.4 billion.
The drugmaker said in a statement, that it continues to stand behind its product but that the payout allows it to focus on its future, while reducing "the uncertainties of complex litigation."